Table 1.

Characteristics of patients with Graves' ophthalmopathy (GO) and non-GO control subjects included in this study.

	GO patients (n = 6)	Control subjects (n = 6)
Mean age (years)	44.0 ± 12.3	42.7 ± 11.3
Sex (male/female)	2/4	2/4
Smoking (n)	2	1
Duration of GD (months)	46.3 ± 9.7	—
Duration of GO (months)	33.8 ± 8.0	—
Previous orbital irradiation	0	—
Previous steroid pulse therapy	0	—
Euthyroid	6	6
TSH receptor antibodies	6	0
Clinical activity score	1.5 ± 0.5

GD = Graves' disease; TSH = thyroid-stimulating hormone.